Author
Swetha Kulkarni
2 posts
Breakthrough Therapy Designation for Roche’s Gazyva
24 Sep 2019
Roche’s Gazyva (obinutuzumab) gets BTD in Lupus Nephritis As of the press release on 18th September 2019, The Gazyva®(obinutuzumab) from Roche received the Breakthrough Therapy Designation…
Lupin Ltd signs $700 Million deal to develop anti-cancer drug
9 Sep 2019
Anti-cancer drug deal by Lupin and Boehringer Ingelheim worth $700 mn In a press release on 4th September 2019, Lupin Ltd and Boehringer Ingelheim announced a…